• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD Back to Search Results
Model Number 4542
Medical Device Problem Codes Pacing Problem (1439); Extracardiac stimulation (1463); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Muscle Stimulation (1412)
Date of Event 02/16/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event or Problem Description
Boston scientific received information that this left ventricular (lv) lead exhibited pacing inhibition and was found to be dislodged one day post implant.The patient experienced stimulation, however, did not experience any symptoms as a result of the pacing inhibition.An invasive procedure was performed.The lead was explanted and replaced with another manufacturer's lead.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Resistance and pressure tests were completed to assess lead electrical performance and insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
MDR Report Key6480398
Report Number2124215-2017-04044
Device Sequence Number19154721
Product Code NIK
UDI-Device Identifier00802526579806
UDI-Public(01)00802526579806(17)20170428
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P010012/S024
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2017
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/28/2017
Device Model Number4542
Other Device ID NumberEASYTRAK 2
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/01/2017
Was the Report Sent to FDA? Yes
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 02/16/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/11/2017
Supplement Report FDA Received Date04/13/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
0125; 0293; 1783; 4046; 4136; 4542; 4592; G140; N119; N161; T177
Outcome Attributed to Adverse Event Hospitalization; Life Threatening; Required Intervention;
Patient Age47 YR
-
-